SHANGHAI, Aug. 9, 2013 /PRNewswire/ -- Newly improved delivery systems for primary available drugs are not only beneficial for patients but also less complicated while offering needle-free delivery and a reduction in the dose of active ingredients. According to statistics, the global Drug Delivery Systems market is projected to reach $196.4 billion by 2014. And the global injectable drug delivery market is expected to be worth $29.981 billion by 2015. Therefore, huge market opportunities and challenges exist at the same time in NDDS, both for pharma manufacturers and NDDS suppliers.
Organized by CPhI and UBM Conferences, both NDDS 2011 & 2012 were successful in offering a platform for the NDDS industry to network and learn, in addition both forums were highly regarded by the attending delegates. The 3rd NDDS & Clinical Trial Management China 2013 will take place on 27th-28th November at the Crowne Plaza Century Park, Shanghai. This year's edition will deliver themes which will drive cross-industry co-operation, engage in learning about the latest market trends and advancements in both technique and methodology, and to provide a business network environment to the unique participants of this conference. The two-day conference will include 3 chapters: Drug discovery and research fulfillments, Novel pathways for future drug delivery solutions and Biotherapeutic drug delivery towards clinical science development. There will be 16 professional presentations and 2 panel discussions exploring the commercial value, techniques, requirements and clinical science of NDDS. To download the full agenda, please visit www.ndds-china.com.
If you have any questions, please call +86-21-61573930 or send an email to firstname.lastname@example.org.
Ms. Tracy Cui
Tel: +86-21-6157 3919
SOURCE UBM Conferences